At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IINN Inspira Technologies Oxy B.H.N. Ltd.
Trading 01-16 10:44:08 EST
0.8800
-0.0100
-1.12%
High0.9115Low0.8600Vol31.91K
Open0.8639D1 Closing0.8900Amplitude5.79%
Mkt Cap31.64MTradable Cap25.77MTotal Shares35.95M
T/O28.04KT/O Rate0.11%Tradable Shares29.29M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Inspira Technologies Oxy BHN Ltd trading halted, news pending
TIPRANKS  ·  01-14 01:10
Inspira Technologies Oxy BHN Ltd trading halted, news pending
NASDAQ TRADE HALT HALT NEWS PENDING AT 12:07 PM
Reuters  ·  01-14 01:07
NASDAQ TRADE HALT HALT NEWS PENDING AT 12:07 PM
BRIEF-Inspira Technologies Oxy Bhn Ltd To Buy Liquid Biopsy Business For Up To 40% Shares
Reuters  ·  01-08
BRIEF-Inspira Technologies Oxy Bhn Ltd To Buy Liquid Biopsy Business For Up To 40% Shares
Inspira Technologies Oxy BHN Ltd - to Receive $15 Mln Equity Investment at $180 Mln Valuation
THOMSON REUTERS  ·  01-08
Inspira Technologies Oxy BHN Ltd - to Receive $15 Mln Equity Investment at $180 Mln Valuation
Inspira Technologies Oxy BHN Ltd - to Buy Liquid Biopsy Business for up to 40% Shares
THOMSON REUTERS  ·  01-08
Inspira Technologies Oxy BHN Ltd - to Buy Liquid Biopsy Business for up to 40% Shares
Inspira Technologies Announces $15 Million Investment for Liquid Biopsy Expansion
Reuters  ·  01-08
Inspira Technologies Announces $15 Million Investment for Liquid Biopsy Expansion
Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion
GlobeNewswire  ·  01-08
Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion
BRIEF-Inspira Entered Into A Non-Binding Term Sheet With A Company To Acquire Liquid Biopsy Business
Reuters  ·  01-05
BRIEF-Inspira Entered Into A Non-Binding Term Sheet With A Company To Acquire Liquid Biopsy Business
Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation
THOMSON REUTERS  ·  01-05
Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation
Inspira Technologies: as Part of Acquisition, the Company Will Obtain a $15 Mln Equity Investment at a Company Pre-Money Valuation of $180 Mln
THOMSON REUTERS  ·  01-05
Inspira Technologies: as Part of Acquisition, the Company Will Obtain a $15 Mln Equity Investment at a Company Pre-Money Valuation of $180 Mln
Inspira Technologies: Entered Into a Non-Binding Term Sheet With a Company to Acquire Liquid Biopsy Business
THOMSON REUTERS  ·  01-05
Inspira Technologies: Entered Into a Non-Binding Term Sheet With a Company to Acquire Liquid Biopsy Business
Inspira Technologies to Acquire Liquid Biopsy Cancer Diagnostics Platform with $15 Million Investment
Reuters  ·  01-05
Inspira Technologies to Acquire Liquid Biopsy Cancer Diagnostics Platform with $15 Million Investment
Inspira Technologies OXY BHN Ltd. Held Shareholder Meeting
Reuters  ·  01-01
Inspira Technologies OXY BHN Ltd. Held Shareholder Meeting
Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution With 2026 Regulatory and Deployment Milestones
THOMSON REUTERS  ·  2025-12-23
Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution With 2026 Regulatory and Deployment Milestones
Inspira Technologies Oxy BHN Ltd - Payment Activity to Commence With 2026 Fiscal Cycle
THOMSON REUTERS  ·  2025-12-23
Inspira Technologies Oxy BHN Ltd - Payment Activity to Commence With 2026 Fiscal Cycle
Inspira Technologies Reaffirms $49.5 Million Purchase Orders for 2026 Execution
Reuters  ·  2025-12-23
Inspira Technologies Reaffirms $49.5 Million Purchase Orders for 2026 Execution
Inspira Technologies Oxy BHN Ltd Registering for Resale of up to 24,973,528 Ordinary Shares by Selling Shareholder- SEC Filing
THOMSON REUTERS  ·  2025-12-23
Inspira Technologies Oxy BHN Ltd Registering for Resale of up to 24,973,528 Ordinary Shares by Selling Shareholder- SEC Filing
BRIEF-Inspira Secures $1.8M Direct Offering, Adds Additional Equity Deal
Reuters  ·  2025-12-15
BRIEF-Inspira Secures $1.8M Direct Offering, Adds Additional Equity Deal
Inspira Technologies Oxy BHN Ltd - Enters $25 Mln Sepa With Ya
THOMSON REUTERS  ·  2025-12-15
Inspira Technologies Oxy BHN Ltd - Enters $25 Mln Sepa With Ya
Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution
GlobeNewswire  ·  2025-12-15
Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

Introduction

Company Name.
Inspira Technologies Oxy B.H.N. Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.
Issue price:
--